Reneging on the ‘no-profit pledge’ to supply Oxford vaccine
On the say day the release was sent out announcing the partnership with AstraZeneca, Oxford University also tweeted saying that the
Read MoreOn the say day the release was sent out announcing the partnership with AstraZeneca, Oxford University also tweeted saying that the
Read MoreIt is true that while the U.S. took 10 days to breach the one-million mark and the U.K. took 18
Read MoreThe sera from people vaccinated with Covaxin were tested against the same strain used for making the vaccine, another strain
Read MoreOn January 16, the first day of COVID-19 vaccination in the country, at about only 1.91 lakh health-care workers taking
Read MoreIn a tweet on January 14, the Health Ministry said both Covishield and Covaxin approved for restricted use by the
Read MoreTrue, in the U.S., vaccines from both Pfizer and Moderna are available and recipients, who are health-care workers and nursing
Read MoreThe phase-3 clinical trial of Bharat Biotech’s COVID-19 vaccine, Covaxin, by a private hospital in the Bhopal-based Peoples College of
Read MoreThe Ahmedabad-based Zydus Cadilla only recently got the regulatory permission to carry out phase-3 trial and has to begin the
Read MoreScientists, manufacturers and drug regulators have been speeding up the timelines to develop, test and approve vaccines for emergency use.
Read MoreWhile avian influenza virus crossing the species barrier and directly infecting humans happens only occasionally, human-to-human spread has been rare and not sustained. But mutations in the virus or genetic reassortment could likely result in sustained transmission between humans thus increasing the risk of a pandemic influenza.
Read MoreAs on December 4, U.K has reported 2.7 million cases and over 75,500 deaths, the second highest death toll in
Read MoreTransparency in the approval process is vital for gaining the trust of people so that they don’t hesitate to take
Read MoreSince vaccine shortage is expected to last at least for a few months, it may seem appealing to delay or
Read More